Global Liquid Biopsy Market Analysis 2013-2016 - Forecast to 2022 By Disease Indication, Biomarker, Sample Type, Application & Key Companies

Friday, March 3, 2017 1:59 PM UTC

Dublin, March 03, 2017 -- Research and Markets has announced the addition of the "Global Liquid Biopsy Market Analysis 2016 - Forecast to 2022" report to their offering.

Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis.

The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

Scope of the Report

Disease Indication

Breast Cancer
Gastrointestinal Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Leukemia

Biomarker

Exosomes
Circulating Tumor DNA (ctDNA)
Circulating Tumor Cells (CTC)
Single Gene Analysis (PCR Microarrays)
Multi - gene - parallel Analysis (NGS)

Sample Type

Urine Sample based
Blood Sample based
Saliva
Tissue fluids

Application

Molecular Health Monitoring
Therapy Selection for Metastatic Breast Cancer (MBS)
Therapy Selection for Other Metastatic Cancer

Company Profiles

Internap Corporation
CDN Networks
Tata Communications
Level 3 Communications
Google Inc.
Limelight Networks, Inc.
Highwinds Network Group, Inc.
Akamai Technologies, Inc.
Verizon Communications, Inc.
Amazon Web Services, Inc.
CloudFlare, Inc.
Orange S.A.
MaxCDN Enterprise
Ericssion
AT&T Inc.

For more information about this report visit http://www.researchandmarkets.com/research/wtw4hh/global_liquid



CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: In Vitro Diagnostics

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Global Liquid Biopsy Market Analysis 2013-2016 - Forecast to 2022 By Disease Indication, Biomarker, Sample Type, Application & Key Companies

Editor's Picks

Welcome to EconoTimes